Medical Oncologist
CION Cancer Clinics
Can liver cancer come back after a transplant? | CION Cancer Clinics
Liver cancer can come back after a transplant, though for most carefully selected people it does not. Cancer cells that escaped before the operation can grow later, in the new liver or in the lungs or bones. This page explains what makes a return more likely, how follow-up scans and the AFP blood test look for it, and what the tumour board can still offer if it happens. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can liver cancer come back after a liver transplant?
- What makes HCC more likely to come back after a transplant?
- How will the team check whether the cancer has come back?
- What can be done if the cancer comes back?
- Does a transplant mean the cancer is gone for good?
- What this page cannot tell you
- Common questions about cancer returning after a transplant
The short answer
Can liver cancer come back after a liver transplant?
Yes, it can, although for most people chosen carefully for a transplant it does not. A transplant removes the whole diseased liver, but a few cancer cells may already have escaped into the blood before the operation. If they survive, they can grow later in the new liver or elsewhere, most often the lungs or bones.
Why the risk is not the same for everyone
Transplant teams select people whose cancer looks most likely to have stayed inside the liver. That is what the Milan criteria and similar rules try to do: they use the size and number of tumours as a stand-in for something nobody can see directly, which is whether cells have already spread. When the removed liver is examined under the microscope, the team learns much more about your own risk.
Which liver cancer this page is about
This page is about hepatocellular carcinoma (HCC), the cancer that starts in the liver's own cells and is the usual reason for a transplant for cancer. It is not about cancer that spread to the liver from the bowel or elsewhere, where transplant is rarely an option. Bile duct cancer after a transplant is a separate subject.
A return of the cancer is different from a brand new cancer elsewhere. Both are watched for after a transplant.What the team looks at
What makes HCC more likely to come back after a transplant?
Most of these are learned only after the operation, from the pathology report on the removed liver.
The size and number of tumours
More tumours, or larger ones, raise the chance that cells had already escaped. Sometimes the removed liver shows more cancer than the scans did, which is common and nobody's mistake.
Cancer inside blood vessels
The pathologist checks whether cancer had grown into the small veins of the liver. This is called vascular invasion, and it is one of the strongest signs of a higher risk.
How aggressive the cells look
Cells that look very different from normal liver cells, described as poorly differentiated or high grade, tend to behave more aggressively.
Also weighed
- The AFP level before the transplant
- How the tumour responded to bridging treatment
- Whether the cancer was downstaged to qualify
What does not raise the risk
Taking your anti-rejection medicines correctly is not a mistake that brings cancer back. Neither is the donor, a family member's choices or anything the patient ate. Risk comes from the tumour itself.
Not sure whether this applies to you?
Ask an oncologistAfter the operation
How will the team check whether the cancer has come back?
The pathology report sets the plan
Once the removed liver has been examined, your team uses the findings to decide how closely you need to be watched. Higher-risk features usually mean more frequent checks.
Regular scans
Follow-up usually includes CT or MRI scans of the abdomen and chest. Scans are more frequent in the first few years, when most returns are found, and become less frequent later. CION arranges these scans through its diagnostic partners when you are followed up with us.
The AFP blood test
If your AFP was raised before the transplant, it is checked at each visit. A rising level can be an early clue. Our page on a rising AFP after treatment explains how it is read.
Reviewing the anti-rejection plan
Some teams adjust anti-rejection medicines in people at higher risk, for example by using sirolimus or everolimus, which may have some effect against cancer growth. The evidence for this is still limited, and the decision belongs to the transplant team.
Side by side
What can be done if the cancer comes back?
If it comes back as
What the tumour board may consider
One or two spots that can be reached
Surgery, ablation or targeted radiation to remove or destroy them, coordinated through partner hospitals
Several spots, or spread to more than one place
Tablets such as sorafenib or lenvatinib, given at CION
A painful spot in a bone
Radiation to ease pain, alongside other treatment
Any return, in someone with a transplanted liver
Immunotherapy is usually avoided because it can trigger rejection
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Does a transplant mean the cancer is gone for good?
"The whole liver was replaced, so there is nothing left to come back."
The liver is gone, but cells that escaped before the operation cannot be seen on any scan. That is why follow-up scans continue even when you feel completely well.
"If it comes back, nothing more can be done."
Many returns can still be treated, sometimes with surgery or ablation if found early, and otherwise with tablets that aim to slow the cancer and ease symptoms.
"A second transplant will fix it."
A second transplant is very rarely offered for returning cancer, because the cancer is usually outside the liver as well and the new liver would be at the same risk.
"Immunotherapy worked for others, so it should be tried."
After a transplant, immunotherapy can wake the immune system enough to attack the new liver. Read why it is usually avoided before asking for it.
Being straight with you
What this page cannot tell you
It cannot tell you what your own chance of the cancer returning is. That depends on the pathology report, your AFP history and how the cancer behaved before the operation. Your transplant surgeon and oncologist can explain what your report means for you, in words that fit your situation. Figures you read online describe large groups, not one person.
Who this does not apply to
This page does not apply to people who had a liver resection rather than a transplant; their recurrence risk and options are different. It is also not about new cancers of the skin or lymph nodes, which can be linked to anti-rejection medicines and are covered on our page on new cancers after a transplant.
Where CION fits in
Transplants take place at licensed transplant centres. CION's tumour board can review follow-up scans, give a second opinion if something is found, and give systemic treatment in close contact with your transplant team, who manage the anti-rejection medicines.
A new spot on a scan after a transplant is not always cancer. Ask what further tests are planned before assuming the worst.Questions we are asked
Common questions about cancer returning after a transplant
When does liver cancer usually come back after a transplant?
When it does return, it is most often found in the first few years after the operation. That is why scans are more frequent early on. A return later is less common but possible, so your team will tell you how long follow-up continues and when visits can be spaced further apart.
Where in the body does it come back?
It can return in the new liver, but it is often found outside it, most commonly in the lungs, bones, lymph nodes or the adrenal glands. Follow-up scans therefore usually include the chest as well as the abdomen. Bone pain that does not settle should be reported.
What symptoms should make me call the team?
Often there are no symptoms, which is why scans matter. Report new pain in a bone or the chest, a cough that will not settle, weight loss you cannot explain, new pain in the abdomen or yellowing of the eyes. These have many other causes after a transplant too.
Does a rising AFP always mean the cancer is back?
No. AFP can rise for other reasons, and a single result is less useful than a trend. If it keeps rising, your team will usually arrange scans to look for a cause. If your AFP was normal before the transplant, it may not help much in follow-up.
Can the anti-rejection medicines be stopped to fight the cancer?
They cannot simply be stopped, because the new liver would be rejected. Doses may sometimes be lowered or the type changed when cancer returns. That balance is a decision for the transplant team working with the oncologist, never something to change at home.
Are sorafenib and lenvatinib available in India?
Yes, both are available in India and can be used after a transplant, with care because of how they interact with anti-rejection medicines. Your oncologist and transplant team will check your blood levels closely. Ask for a written estimate of costs before starting.
Did we choose the wrong treatment by going for a transplant?
A return does not mean the decision was wrong. For people who qualify, a transplant remains one of the treatments most likely to remove the cancer and the diseased liver together. Cells that escaped before the operation could not have been seen or prevented by any choice the family made.
Can CION review my follow-up scans?
Yes. CION's tumour board can review your scans, reports and AFP results and give a second opinion on what they show and what to do next. Bring the transplant pathology report if you have it. Call the helpline and someone will arrange the review.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Cancer Recurrence
- American Cancer Society — Living as a Liver Cancer Survivor
- NIDDK — Liver Transplant - NIDDK
- American Cancer Society — Immunotherapy for Liver Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Immunotherapy after a liver transplantWhy this treatment is usually avoided in a transplanted liverNew cancers after a liver transplantThe other cancer risk that follow-up watches forRising AFP after treatmentHow to read a blood result that is going upTreatment options if it comes backThe full range of options for a return
Talk to us
Worried about a follow-up scan after your transplant?
Our tumour board can look at your scans, AFP results and pathology report and explain what they show. There is no pressure to change who looks after you. One helpline serves every CION centre.